Drug Developement/Delivery
- Emerging drugs for the treatment of PNH
- Peptide PROTAC in Drug Development
- FGF21 agonist for MASH: Current Status
- Next-Generation mRNA-LNPs: Strategies to Reduce Anti-PEG Antibody Responses
- CD388, a Novel Drug Fc-Conjugate (DFC) to Prevent Influenza Infection
- ADC in Combination with PD-1: Approvals and Clinical Trials
- Summary of ADC Targets For Solid Tumors & Hematological Tumors
- Advances in TROP-2 Directed ADCs
- Bispecific Antibody Drug Conjugates (ADCs): Emerging Trends
- Maytansinoids as Payloads of ADCs: DM1, DM4
